BR112014010892A2 - combinação terapêutica de memantina e baclofeno e composição farmacêutica contendo os mesmos - Google Patents

combinação terapêutica de memantina e baclofeno e composição farmacêutica contendo os mesmos

Info

Publication number
BR112014010892A2
BR112014010892A2 BR112014010892A BR112014010892A BR112014010892A2 BR 112014010892 A2 BR112014010892 A2 BR 112014010892A2 BR 112014010892 A BR112014010892 A BR 112014010892A BR 112014010892 A BR112014010892 A BR 112014010892A BR 112014010892 A2 BR112014010892 A2 BR 112014010892A2
Authority
BR
Brazil
Prior art keywords
baclofen
memantine
pharmaceutical composition
composition containing
therapeutic combination
Prior art date
Application number
BR112014010892A
Other languages
English (en)
Inventor
Varga Balázs
Mária Horváth Csilla
Misnyovszki Melinda
Kovács Péter
Farkas Sándor
Kitka Tamás
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of BR112014010892A2 publication Critical patent/BR112014010892A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

resumo combinação terapêutica de memantina e baclofeno e composição farmacêutica contendo os mesmos a presente invenção relaciona-se com a combinação de ingredientes ativos de memantina e baclofeno, e também ao processo para a obtenção de perda de peso do corpo e, assim, o tratamento de obesidade e co-morbidades relacionadas pela co-administração de baclofen e memantina.
BR112014010892A 2011-11-07 2012-11-06 combinação terapêutica de memantina e baclofeno e composição farmacêutica contendo os mesmos BR112014010892A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1100615A HU230263B1 (hu) 2011-11-07 2011-11-07 Memantin és baclofen hatóanyagokat tartalmazó kombinációs készítmény
PCT/HU2012/000119 WO2013068774A1 (en) 2011-11-07 2012-11-06 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them

Publications (1)

Publication Number Publication Date
BR112014010892A2 true BR112014010892A2 (pt) 2017-06-13

Family

ID=89990495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014010892A BR112014010892A2 (pt) 2011-11-07 2012-11-06 combinação terapêutica de memantina e baclofeno e composição farmacêutica contendo os mesmos

Country Status (22)

Country Link
US (1) US20140316007A1 (pt)
EP (1) EP2776019A1 (pt)
JP (1) JP2014532752A (pt)
KR (1) KR20140090203A (pt)
CN (1) CN103930099A (pt)
AU (1) AU2012335358A1 (pt)
BR (1) BR112014010892A2 (pt)
CA (1) CA2853872A1 (pt)
CL (1) CL2014001167A1 (pt)
CO (1) CO6970599A2 (pt)
CR (1) CR20140264A (pt)
CU (1) CU20140052A7 (pt)
EA (1) EA201490935A1 (pt)
HK (1) HK1200101A1 (pt)
HU (1) HU230263B1 (pt)
IL (1) IL232232A0 (pt)
IN (1) IN2014KN01142A (pt)
MX (1) MX2014005499A (pt)
NI (1) NI201400039A (pt)
PE (1) PE20141576A1 (pt)
SG (1) SG11201401693UA (pt)
WO (1) WO2013068774A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040102525A1 (en) * 2002-05-22 2004-05-27 Kozachuk Walter E. Compositions and methods of treating neurological disease and providing neuroprotection
WO2008018275A1 (fr) * 2006-08-11 2008-02-14 National University Corporation Nagoya University Agent anti-obésité et son utilisation
CN101500610A (zh) * 2006-08-11 2009-08-05 国立大学法人名古屋大学 抗肥胖药及其利用

Also Published As

Publication number Publication date
CL2014001167A1 (es) 2014-07-04
CN103930099A (zh) 2014-07-16
HK1200101A1 (en) 2015-07-31
KR20140090203A (ko) 2014-07-16
CR20140264A (es) 2014-07-11
CA2853872A1 (en) 2013-05-16
HU230263B1 (hu) 2015-11-30
CO6970599A2 (es) 2014-06-13
EA201490935A1 (ru) 2014-08-29
NI201400039A (es) 2014-10-02
PE20141576A1 (es) 2014-11-06
US20140316007A1 (en) 2014-10-23
WO2013068774A1 (en) 2013-05-16
EP2776019A1 (en) 2014-09-17
HUP1100615A2 (en) 2013-06-28
MX2014005499A (es) 2015-02-20
SG11201401693UA (en) 2014-05-29
JP2014532752A (ja) 2014-12-08
AU2012335358A1 (en) 2014-05-29
CU20140052A7 (es) 2014-07-30
IL232232A0 (en) 2014-06-30
IN2014KN01142A (pt) 2015-10-16

Similar Documents

Publication Publication Date Title
BR112013022789A2 (pt) composições farmacêuticas que compreendem metformina e um inibidor dpp-4 ou um inibidor sglt-2
IN2014DN06501A (pt)
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
AR092177A1 (es) Metodos para tratar o prevenir asma administrando un antagonista de il-4r
TN2015000278A1 (en) Autotaxin inhibitors
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
EA201391644A1 (ru) Частично насыщенные трициклические соединения и способы их получения и применения
BR112015018168A2 (pt) inibidores de rock suaves
BR112014009866A2 (pt) formulações de anticorpos e métodos
BR112014002674A2 (pt) 3-(bifenil-3-il)-4-hidróxi-8-metóxi-1-azaspiro[4.5]dec-3-en-2-onas substituídas
MX2013003635A (es) Compuestos de n-heteroarilo.
BR112014019399A2 (pt) métodos de tratamento da fibrose
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
BR112016013754A2 (pt) Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
BR112015001619A2 (pt) manosídeos multiméricos, um processo para a preparação dos mesmos e as suas utilizações como um medicamento
BR112015000616A2 (pt) tratamento da esclerose múltipla com combinação de laquinimode e fampridina
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
BR112014024033A8 (pt) Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales
BR112012028906A2 (pt) polimorfos de benzoato de alogliptina
MX2015008171A (es) Formulacion que comprende agomelatina amorfa.
UA115307C2 (uk) Застосування лікарського засобу, що містить рекомбінантний лектин омели для лікування раку шкіри

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]